1 Min Read
* FIRST ORDER TO VIBROSENSE DYNAMICS IN THE AREA OF TREATMENT OF CANCER WITH CHEMOTHERAPY
* SAYS CLINIC INTENDS TO CONDUCT A CIPN STUDY AND THUS EXTEND LICENSE AGREEMENT. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.